Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · IEX Real-Time Price · USD
0.405
-0.025 (-5.81%)
Jul 22, 2024, 10:20 AM EDT - Market open
Petros Pharmaceuticals Employees
Petros Pharmaceuticals had 21 employees as of December 31, 2023. The number of employees decreased by 3 or -12.50% compared to the previous year.
Employees
21
Change (1Y)
-3
Growth (1Y)
-12.50%
Revenue / Employee
$223,487
Profits / Employee
-$974,105
Market Cap
2.87M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 21 | -3 | -12.50% |
Dec 31, 2022 | 24 | 0 | - |
Dec 31, 2021 | 24 | -3 | -11.11% |
Dec 31, 2020 | 27 | -18 | -40.00% |
Dec 31, 2019 | 45 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Aditxt | 47 |
TC Biopharm (Holdings) | 41 |
Healthcare Triangle | 31 |
INVO Bioscience | 30 |
Virax Biolabs Group | 11 |
Alzamend Neuro | 7 |
CNS Pharmaceuticals | 5 |
Avenue Therapeutics | 3 |
PTPI News
- 2 days ago - NextTrip, Inc. Receives Nasdaq Notification Regarding Late 10-Q Filing and Continued Listing Requirements - Accesswire
- 4 days ago - NextTrip Taps Dooya Media Group To Launch Compass.TV - Accesswire
- 6 days ago - Petros Pharmaceuticals' STENDRA(R) (avanafil) Pivotal Consumer Self-Selection Study for Over-the-Counter Access Demonstrates Statistical Significance - Accesswire
- 11 days ago - NextTrip Launches FlexPay Travel Payment Options for Bookings - Accesswire
- 4 weeks ago - NextTrip, Inc Receives Nasdaq Notification Regarding Late 10K Filing and Continued Listing Requirements - Accesswire
- 2 months ago - Petros Pharmaceuticals Launches U.S. Distribution of Prescription ED Medication STENDRA Through Recently Announced Collaboration With Lemonaid Health, a Subsidiary of 23andMe - Accesswire
- 3 months ago - Petros Pharmaceuticals Expands Online Distribution for Prescription STENDRA(R) (avanafil) Through New Agreement with Lemonaid Health - Accesswire
- 3 months ago - Petros Pharmaceuticals Receives Positive Response from FDA Following Recent Demonstration of Technology Component in Pursuit of OTC Status for STENDRA(R) (avanafil) - Accesswire